Rinascera Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.5M
- Investors
-
2
Rinascera Therapeutics General Information
Description
The company is currently operating in stealth mode.
Contact Information
Corporate Office
- 75 Kneeland Street, Floor 14
- Boston, MA 02111
- United States
Corporate Office
- 75 Kneeland Street, Floor 14
- Boston, MA 02111
- United States
Rinascera Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 08-Oct-2025 | $2.5M | Completed | Stealth |
Rinascera Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Rinascera Therapeutics Patents
Rinascera Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024210779-A1 | Compositions and formulations for the prevention, treatment, and improvement of skin diseases, conditions, and disorders | Pending | 20-Jan-2023 | ||
| EP-4651873-A1 | Compositions and formulations for the prevention, treatment, and improvement of skin diseases, conditions, and disorders | Pending | 20-Jan-2023 | ||
| AU-2022348566-A1 | Compositions and formulations for topical use of an akt inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders | Pending | 15-Sep-2021 | ||
| EP-4401732-A1 | Compositions and formulations for topical use of an akt inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders | Pending | 15-Sep-2021 | ||
| EP-4401732-A4 | Compositions and formulations for topical use of an akt inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders | Pending | 15-Sep-2021 | A61K31/4439 |
Rinascera Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Double Point Ventures | Venture Capital | Minority | ||
| Olive Tree Capital | Venture Capital | Minority |
Rinascera Therapeutics FAQs
-
When was Rinascera Therapeutics founded?
Rinascera Therapeutics was founded in 2025.
-
Where is Rinascera Therapeutics headquartered?
Rinascera Therapeutics is headquartered in Boston, MA.
-
What industry is Rinascera Therapeutics in?
Rinascera Therapeutics’s primary industry is Other Commercial Products.
-
Is Rinascera Therapeutics a private or public company?
Rinascera Therapeutics is a Private company.
-
What is the current valuation of Rinascera Therapeutics?
The current valuation of Rinascera Therapeutics is .
-
What is Rinascera Therapeutics’s current revenue?
The current revenue for Rinascera Therapeutics is .
-
How much funding has Rinascera Therapeutics raised over time?
Rinascera Therapeutics has raised $2.5M.
-
Who are Rinascera Therapeutics’s investors?
Double Point Ventures and Olive Tree Capital have invested in Rinascera Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
